在阿司匹林加重呼吸道疾病的临床和机械学的进步
Shabnam Elahi1, Anju T Peters1, Atsushi Kato1
1Division of Allergy and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Ill.
The Journal of allergy and clinical immunology
|March 20, 2025
概括
阿司匹林加重的呼吸道疾病 (AERD) 涉及喘,鼻和NSAID敏感性. 这一审查探讨了AERDD.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 阿司匹林加剧的呼吸系统疾病 (AERD) 影响着高达15%的喘患者或具有鼻息肉的慢性鼻炎患者.
- 患有AERD的患者对非类固醇抗炎药物 (NSAID) 过敏,在摄入后迅速发展呼吸系统症状.
- AERD与更严重的上下呼吸道疾病有关,即使没有NSAID触发剂.
研究的目的:
- 审查AERD.病变发生过程中的新型机械学发现.
- 讨论最近AERD.临床理解和管理方面的进展.
主要方法:
- 审查关于AERD病原和临床管理的当前文献.
- 对甲基酸代谢,炎症,上皮屏障功能和AERD中的纤维素失衡的机制性见解的综合.
主要成果:
- AERD的发病过程涉及复杂的相互作用,包括阿拉基酸路径失调,异常炎症,呼吸上皮质屏障受损和局部纤维素失衡.
- 最近的研究突出了AERD背后的特定分子和细胞机制.
结论:
- 了解AERD复杂的发病机制对于开发向疗法至关重要.
- 临床管理方面的进展为患有AERD的患者提供了更好的结果.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
329
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
329
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Pathogenesis and Clinical Features
219
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
219
Acute Respiratory Failure-V
113
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
113
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


